Xenetic Biosciences (XBIO) Accumulated Expenses (2011 - 2026)

Xenetic Biosciences (XBIO) has 15 years of Accumulated Expenses data on file, last reported at $399431.0 in Q1 2026.

• Quarterly Accumulated Expenses fell 6.6% year-over-year to $399431.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $399431.0 (down 6.6% YoY) and the FY2025 annual result came in at $709916.0, up 16.26% from the prior year.
• Accumulated Expenses declined to $399431.0 in Q1 2026, from $709916.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.3 million in Q2 2024 to a low of $399431.0 in Q1 2026.
• A 5-year average of $674865.1 and a median of $619939.0 in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 100.61% — and 2025, when it slumped 57.32%.
• Tracing XBIO's Accumulated Expenses over 5 years: stood at $785796.0 in 2022, then retreated by 27.62% to $568753.0 in 2023, then climbed by 7.37% to $610648.0 in 2024, then gained by 16.26% to $709916.0 in 2025, then plunged by 43.74% to $399431.0 in 2026.
• The last three Accumulated Expenses figures came in at $399431.0 (Q1 2026), $709916.0 (Q4 2025), and $533525.0 (Q3 2025), per Business Quant data.